Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Virtual Brain Modelling Reveals Altered Network Dynamics and Predicts Symptom Severity in Schizophrenia: Relevance to Antipsychotic Treatment Response and Resistance. Local targets link to admitted publications; unresolved targets remain external evidence.
Schizophrenia-An Overview
10.1001/jamapsychiatry.2019.3360 · 2020 · External reference
10.1007/978-0-387-78665-0_87
10.1007/978-0-387-78665-0_87 · External reference
The lived experience of psychosis: a bottom-up review co-written by experts by experience and academics
10.1002/wps.20959 · 2022 · External reference
: The Lived Experiences of Family Members and Carers of People with Psychosis: A Bottom-Up Review Co-Written by Experts by Experience and Academics
10.1159/000528513 · 2023 · External reference
10.1038/s41380-023-02138-4
10.1038/s41380-023-02138-4 · External reference
: Suicide in Schizophrenia: An Educational Overview
10.3390/medicina55070361 · 2019 · External reference
What is schizophrenia – symptomatology
10.1017/s1092852924000622 · 2025 · External reference
10.1093/schbul/sbp006
10.1093/schbul/sbp006 · External reference
10.1016/j.biopsych.2022.06.017
10.1016/j.biopsych.2022.06.017 · External reference
10.1038/s41582-023-00904-0
10.1038/s41582-023-00904-0 · External reference
10.3389/fncel.2024.1386583
10.3389/fncel.2024.1386583 · External reference
10.1016/bs.apha.2016.01.006
10.1016/bs.apha.2016.01.006 · External reference
10.1093/schbul/sbs076
10.1093/schbul/sbs076 · External reference
10.1523/jneurosci.4650-03.2004
10.1523/jneurosci.4650-03.2004 · External reference
10.1016/j.tins.2014.12.005
10.1016/j.tins.2014.12.005 · External reference
10.1016/j.neuron.2013.02.011
10.1016/j.neuron.2013.02.011 · External reference
In vivo assessment of GABAergic inhibition and glutamate facilitation in treatment-resistant schizophrenia: a TMS study integrating clinical, cognitive, and neurophysiological evaluations
10.1038/s41537-025-00634-w · 2025 · External reference
: Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients
10.1016/j.pnpbp.2021.110493 · 2022 · External reference
Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain
10.1038/s41537-022-00231-1 · 2022 · External reference
10.1016/j.biopsych.2015.08.025
10.1016/j.biopsych.2015.08.025 · External reference
Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia
10.1001/jamapsychiatry.2015.2680 · 2016 · External reference
: Cognitive Impairment Associated with Schizophrenia: From Pathophysiology to Treatment
10.1146/annurev-pharmtox-051921-093250 · 2023 · External reference
Hippocampal circuit dysfunction in psychosis
2022 · External reference
10.1038/s41380-023-01949-9
10.1038/s41380-023-01949-9 · External reference
10.1017/s1092852914000601
10.1017/s1092852914000601 · External reference
10.1093/schbul/sbu170
10.1093/schbul/sbu170 · External reference
: CONNEX, a Phase III Randomized Trial Program Assessing Efficacy and Safety of Iclepertin in Schizophrenia: Recruitment and Baseline Characteristics
10.1192/bjo.2024.230 · 2024 · External reference
Efficacy and safety of the novel glycine transporter inhibitor BI 425809 once daily in patients with schizophrenia: a double-blind, randomised, placebo-controlled phase 2 study
10.1016/s2215-0366(20)30513-7 · 2021 · External reference
Unresolved reference
External reference
Current Findings and Potential Mechanisms of KarXT (Xanomeline–Trospium) in Schizophrenia Treatment
10.1007/s40261-024-01377-9 · 2024 · External reference
10.1038/s41380-026-03543-1
10.1038/s41380-026-03543-1 · External reference
: A New Antipsychotic for Schizophrenia: Xanomeline and Trospium (Cobenfy)
10.1080/01612840.2024.2427561 · 2024 · External reference
10.1152/jn.00338.2011
10.1152/jn.00338.2011 · External reference
10.1093/schbul/sbx034
10.1093/schbul/sbx034 · External reference
10.1093/schbul/sbad022
10.1093/schbul/sbad022 · External reference
Early life stress, low-grade systemic inflammation and weaker suppression of the default mode network (DMN) during face processing in Schizophrenia
10.1038/s41398-023-02512-4 · 2023 · External reference
10.1093/schbul/sby094
10.1093/schbul/sby094 · External reference
: Posterior Cerebellar Resting-State Functional Hypoconnectivity: A Neural Marker of Schizophrenia Across Different Stages of Treatment Response
10.1016/j.biopsych.2024.01.027 · 2024 · External reference
10.1101/2024.10.25.620271
10.1101/2024.10.25.620271 · External reference
10.3389/fpsyt.2024.1474313
10.3389/fpsyt.2024.1474313 · External reference
Abnormal Ventral and Dorsal Attention Network Activity during Single and Dual Target Detection in Schizophrenia
2016 · External reference
10.1111/ejn.15889
10.1111/ejn.15889 · External reference
: Neural substrates of verbal memory impairment in schizophrenia: A multimodal connectomics study
10.1002/hbm.26248 · 2023 · External reference
: Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
10.1176/appi.ajp.2016.16050503 · 2017 · External reference
: Molecular Underpinning of Treatment-Resistant Schizophrenia: A Putative Different Neurobiology from Treatment-Responsive Schizophrenia
10.3390/ijms26178598 · 2025 · External reference
Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses
10.1016/j.psychres.2013.06.042 · 2013 · External reference
: Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics’ Treatment of Schizophrenia
10.3390/cells12040574 · 2023 · External reference
: Dopamine Dynamics and Neurobiology of Non-Response to Antipsychotics, Relevance for Treatment Resistant Schizophrenia: A Systematic Review and Critical Appraisal
10.3390/biomedicines11030895 · 2023 · External reference
Why Is Clozapine Uniquely Effective in Treatment-Resistant Schizophrenia? A Review and Proposal
10.1016/j.biopsych.2025.06.011 · 2026 · External reference
Assessment of NMDA receptor activation in vivo by Fos induction after challenge with the direct NMDA agonist (tetrazol-5-yl) glycine: effects of clozapine and haloperidol
10.1007/s00702-007-0628-5 · 2007 · External reference
10.1016/j.lfs.2008.05.014
10.1016/j.lfs.2008.05.014 · External reference
10.1177/02698811251319458
10.1177/02698811251319458 · External reference
10.1016/j.tins.2022.06.007
10.1016/j.tins.2022.06.007 · External reference
10.64898/2026.05.06.26352533
10.64898/2026.05.06.26352533 · External reference
10.1523/jneurosci.5068-13.2014
10.1523/jneurosci.5068-13.2014 · External reference
10.3389/fnagi.2022.868342
10.3389/fnagi.2022.868342 · External reference
10.3389/fnagi.2023.1204134
10.3389/fnagi.2023.1204134 · External reference
Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosis
10.1093/ijnp/pyaf078 · 2026 · External reference
Unresolved reference
External reference
10.1176/appi.ajp.2009.09060802
10.1176/appi.ajp.2009.09060802 · External reference
10.1016/j.neuroimage.2011.09.015
10.1016/j.neuroimage.2011.09.015 · External reference
10.1002/ima.22005
10.1002/ima.22005 · External reference
10.1016/s1361-8415(02)00054-3
10.1016/s1361-8415(02)00054-3 · External reference
10.1016/j.neuroimage.2011.06.080
10.1016/j.neuroimage.2011.06.080 · External reference
10.1016/j.neuroimage.2007.04.042
10.1016/j.neuroimage.2007.04.042 · External reference
10.1006/nimg.2001.0978
10.1006/nimg.2001.0978 · External reference
10.1016/j.neuroimage.2011.02.046
10.1016/j.neuroimage.2011.02.046 · External reference
10.1016/j.neuroimage.2006.05.056
10.1016/j.neuroimage.2006.05.056 · External reference
10.1016/j.neuroimage.2012.06.005
10.1016/j.neuroimage.2012.06.005 · External reference
10.3389/fncel.2020.00240
10.3389/fncel.2020.00240 · External reference
10.1016/j.neuroimage.2019.116137
10.1016/j.neuroimage.2019.116137 · External reference
10.1016/j.neuroimage.2014.11.001
10.1016/j.neuroimage.2014.11.001 · External reference
10.1152/jn.00339.2011
10.1152/jn.00339.2011 · External reference
10.1016/j.neuroimage.2022.118973
10.1016/j.neuroimage.2022.118973 · External reference
10.1093/biomet/6.1.1
10.1093/biomet/6.1.1 · External reference
10.2307/3001968
10.2307/3001968 · External reference
X. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling. The London
10.1080/14786440009463897 · 1900 · External reference
Unresolved reference
External reference
10.2307/2280779
10.2307/2280779 · External reference
: Regression Shrinkage and Selection Via the Lasso
10.1111/j.2517-6161.1996.tb02080.x · 1996 · External reference
: Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
10.1111/j.2517-6161.1995.tb02031.x · 1995 · External reference
10.1016/j.psychres.2020.112957
10.1016/j.psychres.2020.112957 · External reference
10.1001/archpsyc.62.5.495
10.1001/archpsyc.62.5.495 · External reference
Alterations of the occipital lobe in schizophrenia
10.17712/nsj.2015.3.20140757 · 2015 · External reference
10.18999/nagjms.80.3.317
10.18999/nagjms.80.3.317 · External reference
10.3389/fpsyt.2025.1566184
10.3389/fpsyt.2025.1566184 · External reference
: Reduced intrinsic visual cortical connectivity is associated with impaired perceptual closure in schizophrenia
10.1016/j.nicl.2017.04.012 · 2017 · External reference
Consistent frontal-limbic-occipital connections in distinguishing treatment-resistant and non-treatment-resistant schizophrenia
10.1016/j.nicl.2024.103726 · 2025 · External reference
: Altered Patterns of Brain Glucose Metabolism Involve More Extensive and Discrete Cortical Areas in Treatment-resistant Schizophrenia Patients Compared to Responder Patients and Controls: Results From a Head-to-Head 2-[18F]-FDG-PET Study
2022 · External reference
10.1016/j.eurpsy.2015.01.002
10.1016/j.eurpsy.2015.01.002 · External reference
Disrupted default mode network connectivity and its role in negative symptoms of schizophrenia
10.1016/j.psychres.2025.116489 · 2025 · External reference
10.1016/j.schres.2014.12.026
10.1016/j.schres.2014.12.026 · External reference
10.1038/aps.2017.172
10.1038/aps.2017.172 · External reference
Glutamatergic dysfunction in Schizophrenia
10.1038/s41398-022-02253-w · 2022 · External reference
Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study
10.1038/tp.2017.53 · 2017 · External reference
